Incyte Corp.
NASDAQ:INCY
| Market Cap (Intraday) | 12.93B |
| Current PE | 607.87 |
| Forward PE | 11.78 |
| 2yr Forward PE | 9.92 |
| 10-Day MA | $68.68 |
| 50-Day MA | $66.66 |
| 200-Day MA | $68.15 |
Incyte Corp. Stock, NASDAQ:INCY
1801 Augustine Cut-Off, 1801 Augustine Cut-Off, Wilmington, Delaware 19803
United States of America
Phone: +1.302.498.6700
Number of Employees: 2617
Description
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.